News

GSK has become the latest drugmaker to run into difficulties in developing a drug targeting the immune checkpoint receptor ...
With a portfolio of 14 potential blockbuster treatments that it expects to launch over the next five years, GSK is sticking ...
The FTSE 100 enjoyed another leap towards record territory as the index pushed around 0.7 per cent higher on Tuesday, ...